Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

NCT05677334 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Type2diabetes

Interventions

DRUG: Henagliflozin
DEVICE: Continuous Subcutaneous Insulin Infusion

Sponsor

First Affiliated Hospital of Guangxi Medical University